Experimental therapy tested for devastating childhood brain cancer
NCT ID NCT02742883
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 24 times
Summary
This study is testing whether an experimental treatment called Antineoplaston therapy can help control DIPG, a rare and aggressive brainstem tumor that is very hard to treat. It is enrolling children and adults with DIPG who have either tried standard treatments or have chosen not to use them. The main goal is to see if the treatment shrinks tumors and helps patients live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE INTRINSIC PONTINE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Burzynski Clinic
Houston, Texas, 77055-6330, United States
Conditions
Explore the condition pages connected to this study.